These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26655499)

  • 21. Cx32 exerts anti-apoptotic and pro-tumor effects via the epidermal growth factor receptor pathway in hepatocellular carcinoma.
    Xiang Y; Wang Q; Guo Y; Ge H; Fu Y; Wang X; Tao L
    J Exp Clin Cancer Res; 2019 Apr; 38(1):145. PubMed ID: 30947731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoprotective effect of caffeic acid phenethyl ester on promotion in a medium-term rat hepatocarcinogenesis assay.
    Carrasco-Legleu CE; Márquez-Rosado L; Fattel-Fazenda S; Arce-Popoca E; Pérez-Carreón JI; Villa-Treviño S
    Int J Cancer; 2004 Feb; 108(4):488-92. PubMed ID: 14696111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.
    Yin J; Ding J; Huang L; Tian X; Shi X; Zhi L; Song J; Zhang Y; Gao X; Yao Z; Jing X; Yang J
    Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alcohol consumption promotes diethylnitrosamine-induced hepatocarcinogenesis in male mice through activation of the Wnt/β-catenin signaling pathway.
    Mercer KE; Hennings L; Sharma N; Lai K; Cleves MA; Wynne RA; Badger TM; Ronis MJ
    Cancer Prev Res (Phila); 2014 Jul; 7(7):675-85. PubMed ID: 24778325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression.
    Cheng Q; Yuan F; Lu F; Zhang B; Chen T; Chen X; Cheng Y; Li N; Ma L; Tong T
    Oncotarget; 2015 Mar; 6(7):4733-44. PubMed ID: 25749381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of multiple cell cycle aberrations in early preneoplastic liver cell lesions by tumor promotion with thioacetamide in a two-stage rat hepatocarcinogenesis model.
    Kimura M; Fujii Y; Yamamoto R; Yafune A; Hayashi SM; Suzuki K; Shibutani M
    Exp Toxicol Pathol; 2013 Nov; 65(7-8):979-88. PubMed ID: 23474136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
    Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
    Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical demonstration of the gap junctional protein connexin 32 and proliferating cell nuclear antigen in glutathione S-transferase placental form-negative lesions of rat liver induced by diethylnitrosamine and clofibrate.
    Ito S; Tateno C; Tuda M; Yoshitake A
    Toxicol Pathol; 1996; 24(6):690-5. PubMed ID: 8994295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do the expressions of gap junction gene connexin messenger RNA in noncancerous liver remnants of patients with hepatocellular carcinoma correlate with postoperative recurrences?
    Sheen IS; Jeng KS; Shih SC; Kao CR; Wang PC; Chen CZ; Chang WH; Wang HY; Shyung LR
    World J Gastroenterol; 2005 Jan; 11(2):171-5. PubMed ID: 15633210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-15b-5p induces endoplasmic reticulum stress and apoptosis in human hepatocellular carcinoma, both in vitro and in vivo, by suppressing Rab1A.
    Yang Y; Hou N; Wang X; Wang L; Chang S; He K; Zhao Z; Zhao X; Song T; Huang C
    Oncotarget; 2015 Jun; 6(18):16227-38. PubMed ID: 26023735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Connexin32 regulates hepatoma cell metastasis and proliferation via the p53 and Akt pathways.
    Zhao B; Zhao W; Wang Y; Xu Y; Xu J; Tang K; Zhang S; Yin Z; Wu Q; Wang X
    Oncotarget; 2015 Apr; 6(12):10116-33. PubMed ID: 25426556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CTNNA3 is a tumor suppressor in hepatocellular carcinomas and is inhibited by miR-425.
    He B; Li T; Guan L; Liu FE; Chen XM; Zhao J; Lin S; Liu ZZ; Zhang HQ
    Oncotarget; 2016 Feb; 7(7):8078-89. PubMed ID: 26882563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis.
    Brandon-Warner E; Walling TL; Schrum LW; McKillop IH
    Alcohol Clin Exp Res; 2012 Apr; 36(4):641-53. PubMed ID: 22017344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis.
    Oh BK; Kim YJ; Park YN; Choi J; Kim KS; Park C
    Am J Gastroenterol; 2006 Apr; 101(4):831-8. PubMed ID: 16494581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylated chrysin induces co-ordinated attenuation of the canonical Wnt and NF-kB signaling pathway and upregulates apoptotic gene expression in the early hepatocarcinogenesis rat model.
    Khan MS; Halagowder D; Devaraj SN
    Chem Biol Interact; 2011 Aug; 193(1):12-21. PubMed ID: 21554863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma.
    Shen G; Rong X; Zhao J; Yang X; Li H; Jiang H; Zhou Q; Ji T; Huang S; Zhang J; Jia H
    Carcinogenesis; 2014 Dec; 35(12):2748-55. PubMed ID: 25280563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed liver regeneration and increased susceptibility to chemical hepatocarcinogenesis in transgenic mice expressing a dominant-negative mutant of connexin32 only in the liver.
    Dagli ML; Yamasaki H; Krutovskikh V; Omori Y
    Carcinogenesis; 2004 Apr; 25(4):483-92. PubMed ID: 14688024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor suppression effects of bilberry extracts and enzymatically modified isoquercitrin in early preneoplastic liver cell lesions induced by piperonyl butoxide promotion in a two-stage rat hepatocarcinogenesis model.
    Hara S; Morita R; Ogawa T; Segawa R; Takimoto N; Suzuki K; Hamadate N; Hayashi SM; Odachi A; Ogiwara I; Shibusawa S; Yoshida T; Shibutani M
    Exp Toxicol Pathol; 2014 Aug; 66(5-6):225-34. PubMed ID: 24680176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcription factor Nrf2/MafK regulates rat placental glutathione S-transferase gene during hepatocarcinogenesis.
    Ikeda H; Nishi S; Sakai M
    Biochem J; 2004 Jun; 380(Pt 2):515-21. PubMed ID: 14960151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ras-driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic control.
    Calvisi DF; Pinna F; Pellegrino R; Sanna V; Sini M; Daino L; Simile MM; De Miglio MR; Frau M; Tomasi ML; Seddaiu MA; Muroni MR; Feo F; Pascale RM
    Int J Cancer; 2008 Nov; 123(9):2057-64. PubMed ID: 18697198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.